Alzheimer's Disease Research News

BrightFocus Foundation mourns the recent passing of Peter Davies, PhD—a globally-recognized leader in research on Alzheimer’s and related dementia who also served on our Scientific Review Committee for 11 years.

Inhibiting thyroid hormone (TH) activity helps protect against retinal degeneration in an animal model of AMD.

BrightFocus Foundation announced a free virtual town hall to discuss the challenges currently facing caregivers across America and offer helpful advice to guide us through the coming months.

BrightFocus-funded research by Grantee Sarah Doyle, PhD, finds toll-like receptor 2 (TLR2) to be a bridge between oxidative damage and inflammation in AMD.

BrightFocus Foundation today announced 93 new research grants, a $17.8 million commitment toward ending these age-related neurodegenerative diseases.

Interview with husband and wife co-investigators on past BrightFocus grants, Sarah Doyle, PhD, and Matthew Campbell, PhD, who have made ground-breaking discoveries into the biology of neurodegeneration.